These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 25285809
1. Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats. Jin R, Zhu X, Li G. J Vis Exp; 2014 Sep 17; (91):51956. PubMed ID: 25285809 [Abstract] [Full Text] [Related]
2. Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining. Rousselet E, Kriz J, Seidah NG. J Vis Exp; 2012 Nov 06; (69):. PubMed ID: 23168377 [Abstract] [Full Text] [Related]
6. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke. Yu S, Liu X, Shen Y, Xu H, Yang Y, Ding F. Neuroscience; 2016 Jul 07; 327():44-52. PubMed ID: 27060484 [Abstract] [Full Text] [Related]
8. Transient Middle Cerebral Artery Occlusion with an Intraluminal Suture Enables Reproducible Induction of Ischemic Stroke in Mice. Lemmerman LR, Harris HN, Balch MHH, Rincon-Benavides MA, Higuita-Castro N, Arnold DW, Gallego-Perez D. Bio Protoc; 2022 Feb 05; 12(3):e4305. PubMed ID: 35284595 [Abstract] [Full Text] [Related]
9. Modeling stroke in mice - middle cerebral artery occlusion with the filament model. Engel O, Kolodziej S, Dirnagl U, Prinz V. J Vis Exp; 2011 Jan 06; (47):. PubMed ID: 21248698 [Abstract] [Full Text] [Related]
11. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat. Zhang RL, Zhang L, Jiang Q, Zhang ZG, Goussev A, Chopp M. Brain Res; 2000 Sep 29; 878(1-2):64-71. PubMed ID: 10996136 [Abstract] [Full Text] [Related]
12. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke. Lapergue B, Dang BQ, Desilles JP, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud PO, Mazighi M, Michel JB, Meilhac O, Amarenco P. Stroke; 2013 Mar 29; 44(3):699-707. PubMed ID: 23422087 [Abstract] [Full Text] [Related]
13. Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Li W, Qu Z, Prakash R, Chung C, Ma H, Hoda MN, Fagan SC, Ergul A. Brain Res; 2013 Dec 06; 1541():106-14. PubMed ID: 24144674 [Abstract] [Full Text] [Related]
14. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats. Murakami K, Suzuki M, Suzuki N, Hamajo K, Tsukamoto T, Shimojo M. Brain Res; 2013 Aug 14; 1526():84-93. PubMed ID: 23791950 [Abstract] [Full Text] [Related]
15. A novel mouse model of thromboembolic stroke. Chen Y, Zhu W, Zhang W, Libal N, Murphy SJ, Offner H, Alkayed NJ. J Neurosci Methods; 2015 Dec 30; 256():203-11. PubMed ID: 26386284 [Abstract] [Full Text] [Related]
16. Middle Cerebral Artery Occlusion by an Intraluminal Suture Method. Crupi R, Di Paola R, Esposito E, Cuzzocrea S. Methods Mol Biol; 2018 Dec 30; 1727():393-401. PubMed ID: 29222799 [Abstract] [Full Text] [Related]
17. Optimized mouse model of embolic MCAO: From cerebral blood flow to neurological outcomes. Wang R, Wang H, Liu Y, Chen D, Wang Y, Rocha M, Jadhav AP, Smith A, Ye Q, Gao Y, Zhang W. J Cereb Blood Flow Metab; 2022 Mar 30; 42(3):495-509. PubMed ID: 32312170 [Abstract] [Full Text] [Related]